HDAC2 and cervical carcinoma: HDAC inhibition in non-resistant and resistant cervical cancer lines. The same effect was also observed for nonresistant SiHa cells and cisplatin resistant SiHa cells. Both cells exhibit high expression of HDAC1 and HDAC2, whose activity is decreased by pretreatment with this compound.